Simon Rousseau, PhD

Senior Scientist at Ten63 Therapeutics

Simon Rousseau, PhD has extensive work experience in the field of scientific research. Simon began their career as a Graduate Research Assistant at Texas A&M University in September 2014, where they worked until January 2022. During their time there, they gained valuable experience in conducting research and assisting with various projects. In January 2022, Dr. Rousseau joined BioAgilytix as a Scientist, a position they held until July 2023. Here, they further developed their scientific expertise and contributed to important research initiatives. In July 2023, Dr. Rousseau joined Ten63 Therapeutics as a Senior Scientist, where they continue to utilize their skills and knowledge in scientific research.

Simon Rousseau, PhD, obtained their Bachelor's degree in Biochemistry and Genetics from Texas A&M University between 2011 and 2014. Simon then pursued further education at the same institution and earned their Doctor of Philosophy (PhD) in Biochemistry in the period from 2014 to 2021.

Location

Durham, United States

Links


Org chart

No direct reports

Teams


Offices


Ten63 Therapeutics

Ten63 Therapeutics is a venture-backed startup developing durable therapeutics against some of the world’s most lethal diseases.


Employees

1-10

Links